|
JP2020201068A
|
|
Method of predicting effect of atp augmentation therapy to neurodegenerative disease
|
|
JP2019101961A
|
|
Machine learning system, machine learning device, and machine learning method
|
|
JP2019076063A
|
|
Cell number counting device, cell number counting system and cell number counting method in which fine processing structure is object
|
|
JP2018087179A
|
|
Intracellular atp enhancer
|
|
JP2018135278A
|
|
Medicine for ameliorating cardiovascular disease and/or mitochondrial disease
|
|
JP2018118914A
|
|
Pharmaceutical for ameliorating neurodegenerative diseases
|
|
JP2018080135A
|
|
Medicine for improving parkinsonian syndrome
|
|
JP2014176340A
|
|
Method for determining standard value for measuring data and method for evaluating measuring data using standard value
|
|
JP2011092053A
|
|
Method for searching characteristic of character-related base sequence by two-step pooling method
|
|
JP2010136682A
|
|
Method for determining diabetes onset and/or progression risk
|
|
JP2008148566A
|
|
New human peptide having osteoclast formation inhibition activity
|
|
JP2007020563A
|
|
Method for diagnosing development and/or progression risk of diabetic retinopathy
|
|
JP2007209286A
|
|
Method for judging risk in adverse effect of st mixture
|
|
JP2007074927A
|
|
Method for judging effective dose of methotrexate
|
|
JP2005060303A
|
|
Agent for treating or preventing osteoporosis caused by immobility
|
|
JP2004344039A
|
|
Method for diagnosing risk of type 2 diabetes with calpain 10 gene
|
